NASDAQ: GNTA
Genenta Science Spa Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their GNTA stock forecasts and price targets.

Forecast return on equity

Is GNTA forecast to generate an efficient return?

Company
N/A
Industry
167.46%
Market
89.88%

Forecast return on assets

Is GNTA forecast to generate an efficient return on assets?

Company
N/A
Industry
44.42%

GNTA earnings per share forecast

What is GNTA's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$1.07

GNTA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GNTA$3.96N/AN/A
AKTX$1.13N/AN/A
PYXS$1.16$6.50+460.34%Buy
DOMH$4.99N/AN/A
ADAP$0.27$1.35+402.60%Hold

Genenta Science Spa Stock Forecast FAQ

What is GNTA's earnings growth forecast for 2025-2025?

(NASDAQ: GNTA) Genenta Science Spa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.82%.

Genenta Science Spa's earnings in 2025 is -$9,687,494.

In 2025, GNTA is forecast to generate -$19,570,157 in earnings, with the lowest earnings forecast at -$19,570,157 and the highest earnings forecast at -$19,570,157.

If you're new to stock investing, here's how to buy Genenta Science Spa stock.

What is GNTA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: GNTA) forecast ROE is N/A, which is considered weak.

What is GNTA's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: GNTA) Genenta Science Spa's current Earnings Per Share (EPS) is -$0.53. In 2025, GNTA's EPS is forecast to hit -$1.07 (min: -$1.07, max: -$1.07).

What is GNTA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: GNTA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 44.42%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.